Money is the lifeblood of the league and there are, nonetheless, costs to having so much of it flowing through the system.

In a report released today, David Turkaly from JMP Securities reiterated a Hold rating on Globus Medical (GMED – Research Report). The ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Globus Medical (GMED – Research Report), Glaukos ...

GMED earnings call for the period ending December 31, 2024.

Wall Street analysts expect Globus Medical (GMED) to post quarterly earnings of $0.76 per share in its upcoming report, which indicates a year-over-year increase of 26.7%. Revenues are expected to ...

The company currently has its sales operations distributed across 51 counties worldwide. GMED is a Zacks Rank #3 (Hold) stock, with a Momentum Style Score of A and VGM Score of A. Shares are up 3% ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Globus Medical (GMED) reports results for the quarter ended December 2024. While this widely-known consensus ...

GMED opened at $83.99 on Friday. The business’s fifty day simple moving average is $86.65 and its 200 day simple moving average is $78.62. Globus Medical has a 52 week low of $49.33 and a 52 ...

The company currently has its sales operations distributed across 51 counties worldwide. GMED is a #3 (Hold) on the Zacks Rank, with a VGM Score of A. Momentum investors should take note of this ...

Get Our Latest Research Report on Globus Medical Globus Medical Stock Up 0.0 % Shares of GMED opened at $84.04 on Friday. The stock has a market cap of $11.44 billion, a price-to-earnings ratio of ...